跳至主要内容
临床试验/jRCT1032260439
jRCT1032260439尚未招募不适用

Acceptability and Preliminary Effectiveness of an Online Nutritional Counseling Program for Patients with Type 2 Diabetes Mellitus

未提供0 个研究点目标入组 60 人开始时间: 待定
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized

入排标准

年龄范围
18age old over 至 76age old not(—)
性别
All

入选标准

  • 1.Diagnosed with type 2 diabetes mellitus and currently receiving treatment at a hospital or clinic.
  • 2.Aged between 18 and 75 years at the time of informed consent.
  • 3.Owns a smartphone with internet access.
  • 4.Able to receive communications from study staff via SMS, LINE, or email.
  • 5.Able to photograph and record all meals and beverages consumed using a smartphone.
  • 6.Able to participate in scheduled online nutritional counseling sessions and study-related interviews during the study period.
  • 7.Able to read, write, and communicate fluently in Japanese.
  • 8.Determined by the principal investigator or sub-investigator not to have cognitive impairment.
  • 9.Determined by the principal investigator or sub-investigator to be eligible for dietary fiber intervention.
  • 10.Has received a full explanation of the study, sufficiently understands the study procedures, and has voluntarily provided written informed consent to participate.

排除标准

  • 1.Aged 76 years or older.
  • 2.Determined by a physician to be unsuitable for dietary intervention.
  • 3.Has changed medication for the treatment of type 2 diabetes mellitus within the past 8 weeks.
  • 4.Is currently participating in another clinical research program.
  • 5.Is currently following a dietary fiber-restricted diet as directed by a physician.
  • 6.Has a history of an eating disorder.
  • 7.Is currently taking dietary fiber supplements.
  • 8.Is subject to fluid restriction.
  • 9.Has Crohn's disease, ulcerative colitis, inflammatory bowel disease, irritable bowel syndrome, or intestinal obstruction.
  • 10.Has undergone intestinal surgery within the past 3 months.
  • 11.Has stage 4 or higher chronic kidney disease.
  • 12.Has hyperkalemia.
  • 13.Is currently pregnant.
  • 14.Uses a smartphone that is incompatible with MealLog, including being unable to download or effectively use the application.
  • 15.Has any other condition or reason that, in the opinion of the physician, makes participation inappropriate.

研究者

发起方
未提供

相似试验

尚未招募
不适用
A Randomized, Double-blind, Parallel-group Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Elecoglipron Compared with Placebo in Adults with Type 2 Diabetes Mellitus on Background Insulin (Eluminate-3)Type 2 Diabetes Mellitus
jRCT203126026280
招募中
不适用
A Randomized, Double-blind, Parallel-group Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Elecoglipron and Dapagliflozin in Combination, Compared With Elecoglipron Alone and Dapagliflozin Alone, in Adults With Type 2 Diabetes Mellitus (Eluminate-5)Type 2 Diabetes Mellitus
jRCT2031260261165
招募中
不适用
A Randomized, Double-blind, Parallel-group Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin (Eluminate-4)Type 2 Diabetes Mellitus and Impaired Renal Function
jRCT2031260268118
尚未招募
不适用
A Phase III, Randomised, Double-blind, Study to Evaluate the Effect of Balcinrenone/Dapagliflozin Compared With Dapagliflozin on Renal and Cardiovascular Outcomes in Patients With Chronic Kidney Disease (Stage 3b and 4)Renal Insufficiency, Chronic
jRCT2031260364200
招募中
不适用
A Randomized, Double-blind, Parallel-group Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus (Eluminate-1)Type 2 Diabetes Mellitus
jRCT203126027880